Walter B. Bayubay CLS (ASCP), AMT, MA Ed, CPI

Size: px
Start display at page:

Download "Walter B. Bayubay CLS (ASCP), AMT, MA Ed, CPI"

Transcription

1 Walter B. Bayubay CLS (ASCP), AMT, MA Ed, CPI

2 Biochemical Analysis (Lipid Panel) Analyte Total Cholesterol Reference Range Patient A < LDL-C < HDL-C >/= Triglycerides < Patient B

3 LIPOPROTEINS are macromolecular complexes that serve as transport vehicle of insoluble lipids in the plasma.

4 Structure of Lipoprotein

5 Five Main Classes of Lipoproteins: Chylomicrons Very Low Density Lipoprotein (VLDL) Intermediate Density Lipoprotein (IDL) Low Density Lipoprotein (LDL) High Density Lipoprotein (HDL)

6 RELATIVE SIZES OF LIPOPROTEINS

7 RELATIVE COMPOSITION OF LIPOPROTEINS

8 HDL vs. LDL

9 HDL vs. LDL

10 HDL vs. LDL

11

12 Methods of Lipoprotein Estimation Gradient Gel Electrophoresis Ultracentrifugation - Vertical Auto Profile (VAP) Nuclear Magnetic Resonance (NMR) Ion Mobility - Gas-phase Electrophoresis

13 Gradient Gel Electrophoresis HDL and LDL run in separate polyacrylamide gels Gradients are segmented into different regions LDL 3 segments (S 3 GGE) HDL - 10 segments (S 10 GGE) Segmenting gradient permits better separation of subfractions HDL analysis requires purification of HDL before GGE Lipoproteins identified by lipid (LDL) or protein (HDL) stain Concentrations or relative concentrations determined based on scan of separated lipoproteins

14 Ultracentrifugation Vertical Auto Profile (VAP) Vertical auto profile (VAP) method is a direct single test for measuring comprehensive lipoprotein cholesterol profile. It is based on a well-established method of ultracentrifugation that uses vertical rotor and single density gradient spin.

15 Ultracentrifugation Vertical Auto Profile (VAP) VAP provides cholesterol concentrations of total lipoprotein, high-density lipoprotein (HDL), lowdensity lipoprotein (LDL), very-low-density lipoprotein (VLDL), lipoprotein(a) (Lp(a)), intermediate-density lipoprotein (IDL), HDL subclasses (HDL2 and HDL3), LDL subclasses (LDL1, LDL2, LDL3, and LDL4), VLDL subclasses (VLDL1, VLDL2, and VLDL3), and LDL maximum time, which is directly proportional to LDL size.

16 Ultracentrifugation Vertical Auto Profile (VAP) Because VAP measures additional lipoprotein classes, such as Lp(a), IDL, and subclasses of HDL, LDL, and VLDL, it can identify patients at high risk for coronary heart disease who cannot be identified using the standard lipid panel. In addition, the VAP method is compliant with the National Cholesterol Education Program's Adult Treatment Panel III guidelines.

17 Nuclear Magnetic Resonance (NMR) Nuclear magnetic resonance (NMR) spectroscopy measures the number and size of lipoprotein particles instead of their cholesterol or triglyceride content, but its clinical utility is uncertain. Lipoprotein concentrations and size determined from a H-NMR scan of serum No sample preparation required

18 Nuclear Magnetic Resonance (NMR) In one study, cardiovascular disease risk prediction associated with lipoprotein profiles evaluated by NMR was comparable but not superior to that of standard lipids or apolipoproteins. In another study, the magnitude of predictive value of LDL particle concentration (NMR) was not substantively different from that of the total cholesterol to HDL cholesterol ratio and was less than that of C-reactive protein.

19 LIPOPROTEIN FRACTIONATION

20 Ion Mobility Ion mobility lipoprotein fractionation is a technology that uses gas-phase (laminar flow) electrophoresis to separate unmodified lipoproteins on the basis of size. Involves electrophoretic separation of particles in laminar air-flow (Gas-Phase Electrophoretic Macromolecular Mobility Analyzer GEMMA) Technique used routinely to determine particle distributions in aerosol analysis

21 Ion Mobility The size of the lipoprotein particles detected and counted are not affected by particle modifications. (unique property of this method) Ionized lipoprotein particles are electrophoretically separated in a gas phase, and lipoprotein particles are distinguished on the basis of size.

22 Ion Mobility Following the separation, each lipoprotein particle is directly detected and counted as it exits the separation chamber. Size-separated particles are detected and counted by light scattering.

23 Ion Mobility Separation of Lipoprotein

24 Ion Mobility Components Sample Introduction Separation Detection Spray & Dry Aerosol analyzer Detector analyzer voltage light beam Air + CO 2 + HV - a source +1 ions Condenser Liquid Sample filter blower Saturated vapor in detector

25

26 Unit of Measure The ångström (Å) (0.1 nm) is a unit of measure denoting the diameter (size) of a particle. This diameter is used to determine the pattern A vs pattern B LDL phenotype.

27 Pattern A is classified as optimal, and pattern B is classified as high risk. This is based on large population studies showing that people without coronary heart disease tend to have an abundance of large, buoyant LDL particles (pattern A), and people with coronary heart disease tend to have an abundance of smaller, dense LDL particles (pattern B). 7

28 Ideal profile

29 Fractionation by Ion Mobility HDL (alpha) - small - large IDL - small - large LDL (beta) - very small - small plus medium - large VLDL (pre-beta) - small - medium - large

30 Fractionation by Ion Mobility HDL LDL IDL VLDL - small - large - very small - small plus medium - large - small - large - small - medium - large

31 CVD Risk Associations The following CVD risk associations were observed in the Malmo Diet and Cancer Study cardiovascular cohort 2 : High number of small LDL particles: 1.3 times increased risk High number of medium LDL particles: 1.4 times increased risk Low number of large HDL particles: 1.8 times increased risk

32 Ion Mobility vs. Electrophoresis

33 Ideal profile

34 HDL Large equivalent to Apo A1 Apolipoprotein A1 A major protein component of HDL in plasma Promotes fat efflux (including cholesterol), from tissues to the liver for excretion Also isolated as a prostacyclin (PGI2) stabilizing factor, and thus may have an anticlotting effect A stronger prognostic marker for cardiovascular disease

35 Ideal profile

36 LDL Medium + Small concentration - gives better information than LDL-C - principally made of Apo B Apolipoprotein B (Apo B) Major apolipoprotein component of LDL and chylomicrons Responsible for carrying cholesterol to tissues Can lead to plaques that cause vascular disease (atherosclerosis) leading to heart disease Better indicator of heart disease risk than LDL or Total Cholesterol

37 Pattern A vs Pattern B

38 Type B Profile indicates high risk for coronary heart disease

39 Type A Profile indicative of low risk for coronary heart disease

40 Before After

41 Before After

42

43 Analyte Reference Range Patient B Total Cholesterol < LDL-C < HDL-C >/= Triglycerides <

44 Lipoprotein Sub-fraction Reference Ranges Lipoprotein Subtype Females LDL, Peak Diameter Angstrom Males Angstrom LDL, Total nmol/l nmol/l LDL, Medium + Small nmol/l nmol/l LDL, Very Small nmol/l nmol/l Non-HDL nmol/l nmol/l HDL, Large nmol/l nmol/l

45 Lipoprotein Sub-fraction Reference Ranges GOALS Lipoprotein Subtype LDL, Peak Diameter LDL, Total LDL, Medium + Small LDL, Very Small HDL, Large Females and Males > Angstrom < 915 nmol/l < 304 nmol/l < 218 nmol/l < 3017 nmol/l

46 Conclusions: Eighty percent of individuals suffering from coronary heart disease (CAD) have normal cholesterol levels. Half of the 1.5 million heart attacks in the U.S. each year strike people without symptoms also have normal cholesterol levels. Lipid analysis is the only screening test for determining at risk individuals BUT it misses 50% of at risk individuals

47 Lipoprotein fractionation by Ion Mobility offers ability to interrogate lipoproteins within specific groups, HDL, LDL LDL medium + small concentration gives better information than LDL-C (Apo B) HDL large equivalent to HDL-C (Apo A1) LDL particle diameter and concentration used in evaluating therapeutic options

48 Ion mobility provides accurate, reproducible, direct determination of size and concentration for a broad range of lipoprotein particles.

49 Balance Diet

50 Balance Diet

51 Foods that elevate levels of HDL Cholesterol Raw onions ½ of a medium size raw onion can raise HDL as much as 25% Omega-3 fatty acids Include fish, green vegetables and canola oil Soluble fiber Beans, oats, whole grains, fruits like apples, pears and raspberries Monounsaturated fats Olive oil and canola oil

52 Exercise

53

54 THE END Thank you for listening.

Coverage Guidelines. NMR LipoProfile and NMR LipoProfile -II Tests

Coverage Guidelines. NMR LipoProfile and NMR LipoProfile -II Tests Coverage Guidelines NMR LipoProfile and NMR LipoProfile -II Tests Disclaimer: Please note that Baptist Health Plan updates Coverage Guidelines throughout the year. A printed version may not be most up

More information

Lipoprotein Particle Profile

Lipoprotein Particle Profile Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular

More information

Glossary For TheFatNurse s For All Ages Series Apolipoprotein B (APOB or ApoB) are the primary apolipoproteins of chylomicrons and low-density lipoproteins (LDL - known commonly by the misnomer "bad cholesterol"

More information

BIOCHEMISTRY BLOOD - SERUM Result Range Units

BIOCHEMISTRY BLOOD - SERUM Result Range Units BIOCHEMISTRY BLOOD - SERUM Result Range Units LIPIDS CHOLESTEROL 3.9 0.0-5.5 mmol/l TRIGLYCERIDES 0.7 < 1.5 mmol/l LIPID STUDIES HDL(Protective) 1.5 > 1.2 mmol/l LDL(Atherogenic) 2.1 0.5-3.5 mmol/l Cholesterol/HDL

More information

Traceable lipoprotein counting for Cardiovascular disease risk assessment Vincent DELATOUR, PhD

Traceable lipoprotein counting for Cardiovascular disease risk assessment Vincent DELATOUR, PhD Traceable lipoprotein counting for Cardiovascular disease risk assessment Vincent DELATOUR, PhD 1 The need for primary methods VIM 2008 : Primary reference measurement procedure : reference measurement

More information

LIPOPROTEIN PROFILING

LIPOPROTEIN PROFILING LIPOPROTEIN PROFILING in CLINICAL DIAGNOSTICS and LIFE SCIENCE RESEARCH Product Information, March 2015 2004-2015, numares HEALTH LIPOPROTEINS AND CARDIOVASCULAR DISEASE High blood cholesterol is a well-known

More information

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing

More information

Glossary For TheFatNurse s For All Ages Series Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Apolipoprotein

More information

Nutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source

Nutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source Tools: Printer 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut along dashed lines Copyright Goodheart-Willcox Co., Inc. All rights reserved. Tissue in which the body

More information

sad EFFECTIVE DATE: POLICY LAST UPDATED:

sad EFFECTIVE DATE: POLICY LAST UPDATED: Medical Coverage Policy Measurement of Small Low Density Lipoprotein Particles sad EFFECTIVE DATE: 02 16 2010 POLICY LAST UPDATED: 10 15 2013 OVERVIEW Lipoprotein-associated phospholipase A2 (Lp-PLA2),

More information

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids: CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation

More information

Lipid Risk Factors (Novel) in Risk Assessment and Management of Cardiovascular Disease

Lipid Risk Factors (Novel) in Risk Assessment and Management of Cardiovascular Disease Lipid Risk Factors (Novel) in Risk Assessment and Management of Cardiovascular Disease Policy Number: Original Effective Date: MM.02.013 02/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO;

More information

Chapter VIII: Dr. Sameh Sarray Hlaoui

Chapter VIII: Dr. Sameh Sarray Hlaoui Chapter VIII: Dr. Sameh Sarray Hlaoui Lipoproteins a Lipids are insoluble in plasma. In order to be transported they are combined with specific proteins to form lipoproteins: Clusters of proteins and lipids.

More information

Nutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source

Nutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source Nutrition, Food, and Fitness Chapter 6 Fats: A Concentrated Energy Source Tools: Printer (color optional) 4 sheets of 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut

More information

Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant Diabetes

Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant Diabetes Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant Diabetes 2 Michael Cobble, Patrick D. Mize, and Eliot A. Brinton Insulin Resistance and Type 2 Diabetes The pathophysiology of

More information

NOVEL BIOMARKERS IN RISK ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR DISEASE

NOVEL BIOMARKERS IN RISK ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR DISEASE CARDIOVASCULAR DISEASE Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

From HDL Structure to Function - How Structural Information Can Help Address Clinical Need March 17, 2012

From HDL Structure to Function - How Structural Information Can Help Address Clinical Need March 17, 2012 From HDL Structure to Function - How Structural Information Can Help Address Clinical Need March 17, 2012 Teaching Objectives There exists no definitive test for risk of cardiovascular disease. Age and

More information

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol Patrick R. Lawler, MD, MPH; Akintunde O. Akinkuolie, MBBS,

More information

Bringing metabolic profiling into clinical practice. Linda Mustelin, MD, PhD, MPH Senior Medical Scientist Nightingale Health

Bringing metabolic profiling into clinical practice. Linda Mustelin, MD, PhD, MPH Senior Medical Scientist Nightingale Health Bringing metabolic profiling into clinical practice Linda Mustelin, MD, PhD, MPH Senior Medical Scientist Nightingale Health Nightingale Health Ltd. Finnish biotech company specialized in comprehensive

More information

What Else Do You Need to Know? Presenter Disclosure Information. Case 1: Cardiovascular Risk Assessment in a 53-Year-Old Man. Learning Objectives

What Else Do You Need to Know? Presenter Disclosure Information. Case 1: Cardiovascular Risk Assessment in a 53-Year-Old Man. Learning Objectives 9: 1:am Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis SPEAKER Matthew Sorrentino, MD, FACC Presenter Disclosure Information The following relationships exist

More information

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures Lipoprotein (a): Should We Measure? Should We Treat? Joseph P. McConnell, Ph.D. DABCC Health Diagnostic Laboratory Inc. Baptist Health South Florida Eleventh Annual Cardiovascular Disease Prevention International

More information

Lipids Types, Food Sources, Functions

Lipids Types, Food Sources, Functions Lipids Types, Food Sources, Functions What Are Lipids? Lipids Diverse group of molecules that are insoluble in water Fats The lipid content of diets and foods 1 Lipids in Body Cells and Tissues Types of

More information

Lipids do not like water! (aka: hydrophobic) Generally insoluble

Lipids do not like water! (aka: hydrophobic) Generally insoluble Lipids Lipids Lipids do not like water! (aka: hydrophobic) Generally insoluble Lipids They act like this because of their molecular structure (non-polar) Lipids are made mostly of C and H atoms, with O

More information

Insert logo. Linda Main, Dietetic Adviser

Insert logo. Linda Main, Dietetic Adviser Insert logo Linda Main, Dietetic Adviser HEART UK The Cholesterol Charity Our Vision: To prevent avoidable and early deaths caused by high cholesterol. We want the majority of UK adults to know their cholesterol

More information

Metabolism and Atherogenic Properties of LDL

Metabolism and Atherogenic Properties of LDL Metabolism and Atherogenic Properties of LDL Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Faculty of Medicine, University of Palermo, Italy & Affiliate Associate Professor of Internal

More information

Maintain Cholesterol

Maintain Cholesterol Maintain Cholesterol What is Cholesterol? Cholesterol is a Lipid Molecule that has a waxy appearance and is found in every cell of the body and has some important natural functions. It is manufactured

More information

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society

More information

Current Challenges in CardioMetabolic Testing. Kenneth French, Director of Clinical Operations

Current Challenges in CardioMetabolic Testing. Kenneth French, Director of Clinical Operations Current Challenges in CardioMetabolic Testing Kenneth French, Director of Clinical Operations Disclosers Employee at VAP Diagnostics Laboratory Outline Cardiometabolic Disease: Current Challenges and Methodology

More information

BIOB111_CHBIO - Tutorial activity for Session 12

BIOB111_CHBIO - Tutorial activity for Session 12 BIOB111_CHBIO - Tutorial activity for Session 12 General topic for week 6 Session 12 Lipids Useful Links: 1. Animations on Cholesterol (its synthesis, lifestyle factors, LDL) http://www.wiley.com/college/boyer/0470003790/animations/cholesterol/cholesterol.htm

More information

Cholesterol Levels -- What They Mean, Diet and Treatment

Cholesterol Levels -- What They Mean, Diet and Treatment Cholesterol Levels -- What They Mean, Diet and Treatment What Is Cholesterol? We may associate cholesterol with fatty foods, but most of the waxy substance is made by our own bodies. The liver produces

More information

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,

More information

A N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides

A N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides A N A C P S P E C I A L R E P O R T Understanding and Managing Your Triglycerides What are Triglycerides? Triglycerides are one of several types of fat in your body, and the most common of them all. Along

More information

OM s Health Corner Cholesterol & Heart Disease!!

OM s Health Corner Cholesterol & Heart Disease!! Cholesterol & Heart Disease!! We may associate cholesterol with fatty foods, but most of the waxy substance is made by our own bodies. The liver produces 75% of the cholesterol that circulates in our blood.

More information

High-Density Lipoprotein Subclass Testing in the Diagnosis and Management of Cardiovascular Disease. Original Policy Date

High-Density Lipoprotein Subclass Testing in the Diagnosis and Management of Cardiovascular Disease. Original Policy Date MP 2.04.17 High-Density Lipoprotein Subclass Testing in the Diagnosis and Management of Cardiovascular Disease Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date

More information

Measurement of Small Dense Low-density Lipoprotein Particles

Measurement of Small Dense Low-density Lipoprotein Particles 67 Journal of Atherosclerosis and Thrombosis Reviews Vol. 12, No. 2 Measurement of Small Dense Low-density Lipoprotein Particles Tsutomu Hirano 1, Yasuki Ito 2, and Gen Yoshino 3 1 Division of Diabetes

More information

From Food to the Bloodstream

From Food to the Bloodstream FATS The total amount of fat you eat, whether high or low, isn't really linked with disease. What really matters is the type of fat you eat. The "bad" fats saturated and trans fats increase the risk for

More information

Your cholesterol levels. Questions or concerns

Your cholesterol levels. Questions or concerns Because you have high cholesterol you should: Know your cholesterol levels Take the medicine to lower cholesterol that your doctor has told you to take Follow your doctor s treatment plan Keep your appointments

More information

Lipoproteins Metabolism

Lipoproteins Metabolism Lipoproteins Metabolism LEARNING OBJECTIVES By the end of this Lecture, the student should be able to describe: What are Lipoproteins? Describe Lipoprotein Particles. Composition of Lipoproteins. The chemical

More information

Gender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50.

Gender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50. Pro vider: Ordering Provider 123 Main Street Anytown, ST 12345 Account No: DOB: 00/00/1950 Framingham Risk Score: Patient Info: FAMILY HIST CVD Lipid, Lipoprotein and Apolipoprotein Tests Total Cholesterol

More information

Fats and Other Lipids

Fats and Other Lipids Fats and Other Lipids Chapter 6 Chapter 6: Fats and other Lipids 1 6.1 Understanding Lipids Lipids include: 1. Fatty acids 2. Triglycerides 3. Phospholipids 4. Cholesterol Oil and Water Don t Mix Because

More information

MMBS, MMED (Path),MAACB, MACTM, MACRRM

MMBS, MMED (Path),MAACB, MACTM, MACRRM Dr Mere Kende MMBS, MMED (Path),MAACB, MACTM, MACRRM Lecturer- SMSH Brief Overview of Lipids What is dyslipidemia? Classification of hyperlipidemia Primary vs secondary hyperlipidemia Hypercholesterolaemia

More information

Nature Genetics: doi: /ng.3561

Nature Genetics: doi: /ng.3561 Supplementary Figure 1 Pedigrees of families with APOB p.gln725* mutation and APOB p.gly1829glufs8 mutation (a,b) Pedigrees of families with APOB p.gln725* mutation. (c) Pedigree of family with APOB p.gly1829glufs8

More information

Lipids, pt. 1. Feb. 3, Bio 28: Nutrition Instructor: Paul Nagami Laney College

Lipids, pt. 1. Feb. 3, Bio 28: Nutrition Instructor: Paul Nagami Laney College Lipids, pt. 1 Feb. 3, 2014 Bio 28: Nutrition Instructor: Paul Nagami Laney College Today s Agenda Reminders + Administrative Details What Are Lipids? Chemistry and Types of Lipids Fatty Acids Saturated

More information

10/3/2016. SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET. What is a cardiac diet. If it tastes good, spit it out!!

10/3/2016. SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET. What is a cardiac diet. If it tastes good, spit it out!! SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET What is a cardiac diet If it tastes good, spit it out!! 2 1 Heart healthy diet includes: Limiting saturated fat Including unsaturated fats Including omega 3

More information

Dr. Jonathan Spages D.C.

Dr. Jonathan Spages D.C. 17 Natural Ways to Lower Cholesterol Dr. Jonathan Spages D.C. Copyright 2017 All Rights Reserved No part of this book may be reproduced in any form or by any electronic or mechanical means including information

More information

CARDIO Test INFAI. for Cardiac Risk Assessment

CARDIO Test INFAI. for Cardiac Risk Assessment CARDIO Test INFAI for Cardiac Risk Assessment Heart Attack and Stroke: A Worldwide Problem NMR analysis of serum to assess the risk of cardiovascular disease Headquarter in Cologne (RTZ) Facility in Bochum

More information

Pathophysiology of Lipid Disorders

Pathophysiology of Lipid Disorders Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history

More information

Fats, Oils, Triglycerides. About which Americans seem confused

Fats, Oils, Triglycerides. About which Americans seem confused Fats, Oils, Triglycerides About which Americans seem confused Learning Objectives Define fats and oils Understand triglycerides Consider the benefits of saturated fats Identify trans fats in your food

More information

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING REAGENTS RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING Randox sdldl Cholesterol (sdldl-c) Size Matters: The True Wight of Risk in Lipid Profiling 1. BACKGROUND

More information

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Muller H, Jordal O, et al. (998) Replacement of partially hydrogenated soybean

More information

Cholesterol, Heart Attack and Stroke. Dr Tai E Shyong Consultant Department of Endocrinology Singapore General Hospital

Cholesterol, Heart Attack and Stroke. Dr Tai E Shyong Consultant Department of Endocrinology Singapore General Hospital Cholesterol, Heart Attack and Stroke Dr Tai E Shyong Consultant Department of Endocrinology Singapore General Hospital Outline Why are we interested in cholesterol What is a heart attack and how does it

More information

5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT

5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT 5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT Prof. Victor Blaton, Ph.D. Department of Clinical Chemistry, Hospital AZ Sint-Jan

More information

High density lipoprotein metabolism

High density lipoprotein metabolism High density lipoprotein metabolism Lipoprotein classes and atherosclerosis Chylomicrons, VLDL, and their catabolic remnants Pro-atherogenic LDL HDL Anti-atherogenic Plasma lipid transport Liver VLDL FC

More information

High-density lipoproteins: A consensus statement from the National Lipid Association

High-density lipoproteins: A consensus statement from the National Lipid Association Journal of Clinical Lipidology (2013) 7, 484 525 High-density lipoproteins: A consensus statement from the National Lipid Association Peter P. Toth, MD, PhD, FNLA, Chair*, Philip J. Barter, MD, PhD, Co-Chair,

More information

ENERGY NUTRIENTS: THE BIG PICTURE WHY WE EAT FUNCTIONS FATS FAT, CARBS, PROTEIN

ENERGY NUTRIENTS: THE BIG PICTURE WHY WE EAT FUNCTIONS FATS FAT, CARBS, PROTEIN ENERGY NUTRIENTS: FAT, CARBS, PROTEIN Angeline B. David, DRPH, MHS NAD Health Summit March 14, 2013 The science of cooking is not a small matter.... This art should be regarded as the most valuable of

More information

Measurement of Trigly ceride-rich Lipoproteins by Nuclear Magnetic Resonance Spectroscopy

Measurement of Trigly ceride-rich Lipoproteins by Nuclear Magnetic Resonance Spectroscopy Clin. Cardiol. Vol. 22 (Suppl. 11), 11-21-11-27 (1999) Measurement of Trigly ceride-rich Lipoproteins by Nuclear Magnetic Resonance Spectroscopy JAMES CII'VOS, PH.D. Department of Biochemistry, North Carolina

More information

THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS

THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS Hormonal regulation INSULIN lipid synthesis, lipolysis CORTISOL lipolysis GLUCAGON lipolysis GROWTH HORMONE lipolysis CATECHOLAMINES lipolysis LEPTIN catabolism

More information

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC Hypertriglyceridemia: Why, When, and How to Treat Gregory Cohn, MD, FNLA, FASPC DISCLOSURES Consultant to Akcea Therapeutics (in the past 12 months). OUTLINE I. Lipoproteins II. Non-HDL-C III. Causes and

More information

Understanding Cholesterol Holistically

Understanding Cholesterol Holistically Understanding Cholesterol Holistically Dr. Molly Force & Dr. Alicia McCubbins 213 Decatur Street, Port Townsend www.prospernaturalhealth.com (360)385-5375 This presentation is meant for educational use

More information

Where are we heading?

Where are we heading? Unit 5: Where are we heading? Unit 5: Introduction Unit 1: What s in your food? Unit 2: How does your body use food? Unit 3: What is metabolic disease? Unit 4: How do I identify good and bad food? Unit

More information

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries Lipid Disorders in Diabetes (Diabetic Dyslipidemia) Khosrow Adeli PhD, FCACB, DABCC Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University it of Toronto Diabetes A Global

More information

Topic 11. Coronary Artery Disease

Topic 11. Coronary Artery Disease Topic 11 Coronary Artery Disease Lipid metabolism http://news.bbc.co.uk/2/hi/health/7372495.stm Sterol Metabolism and Coronary Artery Disease Big Picture: Exogenous Cholesterol and Fat Metabolism Fats-Triglycerides

More information

History. Aron first proposed that fat may be essential for normal growth Tested on animals-vitamins A,D,E added. Fat deficiency severely affected

History. Aron first proposed that fat may be essential for normal growth Tested on animals-vitamins A,D,E added. Fat deficiency severely affected Chapter 5 LIPIDS History 1918 Aron first proposed that fat may be essential for normal growth Tested on animals-vitamins A,D,E added Fat deficiency severely affected Bone growth Reproduction Called Vitamin

More information

Test Definition: FNMR2 NMR LipoProfile w/ir Markers

Test Definition: FNMR2 NMR LipoProfile w/ir Markers Reporting Title: Performing Location: Labcorp Burlington Specimen Requirements: Submit only one of the following specimens: Serum Draw blood in a plain red-top tube(s). (Serum gel tube is not acceptable.)

More information

Weight Loss NOTES. [Diploma in Weight Loss]

Weight Loss NOTES. [Diploma in Weight Loss] Weight Loss NOTES [Diploma in Weight Loss] Fat s: The good, the bad and the ugly Fat s function in your body 1. Energy stores 2. Muscle fuel 3. Transportation 4. Cell membrane 5. Padding 6. Muscle fuel

More information

PREDIABETES TESTING SERVICES

PREDIABETES TESTING SERVICES PREDIABETES TESTING SERVICES ASSESSING DIABETES RISK IN ASYMPTOMATIC ADULTS Depending upon population characteristics, up to 70% of individuals with prediabetes will ultimately progress to diabetes at

More information

Tracking a Killer Molecule

Tracking a Killer Molecule Tracking a Killer Molecule Mercodia Oxidized LDL ELISA www.mercodia.com Mercodia Oxidized LDL ELISA products Product Catalog No Kit size Oxidized LDL ELISA 10-1143-01 96 wells Oxidized LDL competitive

More information

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation Patient: SAMPLE PATIENT DOB: Sex: MRN: 3701 CV Health Plus Genomics - Plasma, Serum & Buccal Swab Methodology: Chemiluminescent, Enzymatic, Immunoturbidimetric, NMR and PCR Lipid Markers Cholesterol LDL-

More information

FoodGate: The break-in, cover-up, and aftermath. Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W.

FoodGate: The break-in, cover-up, and aftermath. Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W. FoodGate: The break-in, cover-up, and aftermath Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W. Osher Mini Med School for the Public, Mar 6, 2018 Decrease

More information

Lipids are used to store and excess energy from extra carbohydrates in animals

Lipids are used to store and excess energy from extra carbohydrates in animals Lipids Lipids are a major source of energy used by cells, however lipids are more difficult for your body to break down. They produce nearly twice the amount of energy than proteins or carbohydrates. Lipids

More information

Free food = 20 calories per serving

Free food = 20 calories per serving FREE FOODS Free food = 20 calories per serving Skimmed butter milk Unsweetened lime / tomato juice Clear Vegetable soup Vegetable salad like tomatoes, cucumber, onion, white radish, lettuce, capsicum.

More information

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015 No. of Printed Pages : 20 MCC-006 POST GRADUATE DIPLOMA IN CLINICAL 0 CARDIOLOGY (PGDCC) Term-End Examination June, 2015 MCC-006 : CARDIO VASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note :

More information

Low-fat dietary pattern and lipoprotein risk factors: the Women s Health Initiative Dietary Modification Trial 1 4

Low-fat dietary pattern and lipoprotein risk factors: the Women s Health Initiative Dietary Modification Trial 1 4 See corresponding editorial on page 829. Low-fat dietary pattern and lipoprotein risk factors: the Women s Health Initiative Dietary Modification Trial 1 4 Barbara V Howard, J David Curb, Charles B Eaton,

More information

numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics

numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics Three benefits of numares 1 Supporting patients to receive better cure based on effective

More information

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry Learning Objectives 1. Define lipoproteins and explain the rationale of their formation in blood. 2. List different

More information

Review of guidelines for management of dyslipidemia in diabetic patients

Review of guidelines for management of dyslipidemia in diabetic patients 2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University

More information

EATING FOR A HEALTHY HEART S A R A Z O O K, R D N, C D, C P H W C

EATING FOR A HEALTHY HEART S A R A Z O O K, R D N, C D, C P H W C EATING FOR A HEALTHY HEART S A R A Z O O K, R D N, C D, C P H W C ANTI-INFLAMMATORY TURMERIC SMOOTHIE The turmeric has a powerful antiinflammatory, curcumin, in it, which is more easily absorbed by our

More information

Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam

Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam Biochemistry Department Plasma lipoproteins & atherosclerosis by Prof.Dr. Maha M. Sallam 1 1. Recognize structures,types and role of lipoproteins in blood (Chylomicrons, VLDL, LDL and HDL). 2. Explain

More information

Are you eating a balanced diet?

Are you eating a balanced diet? Are you eating a balanced diet? Do you know WHAT A BALANCED DIET IS? Eating a balanced diet means choosing a variety of foods & drinks from all the food groups Health Canada recommends 2-3 Tbsp of oil/day

More information

Diet, nutrition and cardio vascular diseases. By Dr. Mona Mortada

Diet, nutrition and cardio vascular diseases. By Dr. Mona Mortada Diet, nutrition and cardio vascular diseases By Dr. Mona Mortada Contents Introduction Diet, Diet, physical activity and cardiovascular disease Fatty Fatty acids and dietary cholesterol Dietary Dietary

More information

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins - Cholesterol: It is a sterol which is found in all eukaryotic cells and contains an oxygen (as a hydroxyl group OH) on Carbon number

More information

Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial

Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial European Heart Journal (2003) 24, 1843 1847 ARTICLE IN PRESS Clinical research Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo

More information

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants Aggregate Report Fasting Biometric Screening CLIENTXXXX May 2, 2014 21,000 participants Contact:404.636.9437~Website:www.atlantahealthsys.com RISK FACTOR QUESTIONNAIRE Participants Percent Do not exercise

More information

What Are Lipids? FaWy Acids Are Key Building Blocks. Lipids Include. Chapter 5 Lipids: Not Just Fat 6/17/16

What Are Lipids? FaWy Acids Are Key Building Blocks. Lipids Include. Chapter 5 Lipids: Not Just Fat 6/17/16 What Are Lipids? Chapter 5 Lipids: Not Just Fat BIOL 103 Essen@al nutrients Provide energy Help transport fat- soluble nutrients throughout the body Contribute greatly to the flavor and texture of food

More information

DIFFERENT METHODS FOR PARTICLE DIAMETER DETERMINATION OF LOW DENSITY AND HIGH DENSITY LIPOPROTEINS COMPARISON AND EVALUATION.

DIFFERENT METHODS FOR PARTICLE DIAMETER DETERMINATION OF LOW DENSITY AND HIGH DENSITY LIPOPROTEINS COMPARISON AND EVALUATION. DIFFERENT METHODS FOR PARTICLE DIAMETER DETERMINATION OF LOW DENSITY AND HIGH DENSITY LIPOPROTEINS COMPARISON AND EVALUATION A Thesis by VIDYA VAIDYANATHAN Submitted to the Office of Graduate Studies of

More information

Incorporating HDL interaction in an ODE model of Atherosclerosis

Incorporating HDL interaction in an ODE model of Atherosclerosis Incorporating HDL interaction in an ODE model of Atherosclerosis Diego Lopez Texas A&M University July 29, 2015 Diego Lopez (TAMU) July 29, 2015 1 / 10 Introduction Atherosclerosis A disease of the arteries

More information

Chapter (5) Etiology of Low HDL- Cholesterol

Chapter (5) Etiology of Low HDL- Cholesterol Chapter (5) Etiology of Low HDL- Cholesterol The aim of this chapter is to summarize the different etiological factors mainly the role of life-style and different disease conditions contributing to the

More information

Chest pain affects 20% to 40% of the general population during their lifetime.

Chest pain affects 20% to 40% of the general population during their lifetime. Chest pain affects 20% to 40% of the general population during their lifetime. More than 5% of visits in the emergency department, and up to 40% of admissions are because of chest pain. Chest pain is a

More information

Lipids. PBHL 211 Darine Hachem, MS, LD

Lipids. PBHL 211 Darine Hachem, MS, LD Lipids PBHL 211 Darine Hachem, MS, LD Outline Functions of lipids in our body Types of lipids Sources of lipids Recommendation of fat intake Fat association with heart diseases Provide energy (9Kcal/g

More information

Do Cholesterol Numbers Really Assess Cardiovascular Risk?

Do Cholesterol Numbers Really Assess Cardiovascular Risk? of people at risk for HEART DISEASE are not identified by routine testing. Visit us at www.spectracell.com Do Cholesterol Numbers Really Assess Cardiovascular Risk? Lipoprotein Particle numbers tell the

More information

Cardio IQ. Managing Residual Risk with Advanced Cardiovascular Insights. Plaque Formation. Outward remodeling of arterial wall. Macrophages ingest

Cardio IQ. Managing Residual Risk with Advanced Cardiovascular Insights. Plaque Formation. Outward remodeling of arterial wall. Macrophages ingest Cardio IQ Managing Residual Risk with Advanced Cardiovascular Insights Plaque Formation Plaque Progression Plaque Rupture Outward remodeling of arterial wall Normal Accumulation of modified LDL particles

More information

The coronary arteries are located along the outside of the heart as seen here which assist in this process.

The coronary arteries are located along the outside of the heart as seen here which assist in this process. LESSON PLAN Title Heart Healthy Eating Target Audience Patients with a high risk of heart disease Name Sydney Method Flip Chart Terminal Objective By the end of the diet instruction, the Patient will be

More information

ADVANCED CARDIOMETABOLIC SCREENING

ADVANCED CARDIOMETABOLIC SCREENING ADVANCED CARDIOMETABOLIC SCREENING INTRODUCTION SignatureMD and its affiliated physicians continuously seek out technology to identify health risk factors before they become serious diseases. SignatureMD

More information

ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism

ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism I. Chylomicrons (exogenous pathway) A. 83% triacylglycerol, 2% protein, 8% cholesterol plus cholesterol esters, 7% phospholipid (esp. phosphatidylcholine)

More information

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both Lluís Masana Vascular Medicine and Metabolism Unit. Sant Joan University Hospital. IISPV. CIBERDEM Rovira i Virgili

More information

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:

More information

Katsuyuki Nakajima, PhD. Member of JCCLS International Committee

Katsuyuki Nakajima, PhD. Member of JCCLS International Committee Katsuyuki Nakajima, PhD Member of JCCLS International Committee Visiting Professor and Scientist Tufts University, Boston, MA & Framingham Offspring Study, Framingham, MA August 20 th, 2011, Tokyo Framingham

More information

Biomarkers (Novel) in Risk Assessment and Management of Cardiovascular Disease

Biomarkers (Novel) in Risk Assessment and Management of Cardiovascular Disease Biomarkers (Novel) in Risk Assessment and Management of Cardiovascular Disease Policy Number: Original Effective Date: MM.02.013 02/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST

More information

CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL

CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL You will notice that the endogenous pathway is very similar to the exogenous pathway What is the average daily amount of triacylglycerol

More information

NUTRITION Nutrition Information: Fats What is fat and are all fats created equal? The terms fatty acids and fats are often used interchangeably, but a fatty acid is the basic unit/building block of a fat

More information